Genenta Science SPA
GNTA2.460USD
+0.160+6.96%
Handelsschluss 11/05, 16:00（ET）Kurse um 15 Minuten verzögert
47.10MMarktkapitalisierung
--KGV TTM
mehr Informationen über Genenta Science SPA Unternehmen
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Genenta Science SPA Informationen
BörsenkürzelGNTA
Name des UnternehmensGenenta Science SPA
IPO-datumDec 15, 2021
CEOMr. Pierluigi Paracchi
Anzahl der mitarbeiter13
WertpapierartDepository Receipt
GeschäftsjahresendeDec 15
AddresseVia Olgettina 58
StadtMILANO
BörseNASDAQ Capital Market Consolidated
LandItaly
Postleitzahl20132
Telefon
Websitehttps://www.genenta.com/
BörsenkürzelGNTA
IPO-datumDec 15, 2021
CEOMr. Pierluigi Paracchi
Führungskräfte von Genenta Science SPA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.30M
-0.13%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.67%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
+11.03%
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
--
--
Ms. Barbara Regonini
Ms. Barbara Regonini
Finance Director
Finance Director
--
-100.00%
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.30M
-0.13%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.67%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
+11.03%
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
--
--
Ms. Barbara Regonini
Ms. Barbara Regonini
Finance Director
Finance Director
--
-100.00%
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sun, Aug 17
Aktualisiert: Sun, Aug 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Paracchi (Pierluigi)
11.99%
IRCCS Ospedale San Raffaele
9.91%
Naldini (Luigi M.D., Ph.D.)
7.24%
Gentner (Bernard)
3.62%
Russo (Carlo)
3.15%
Andere
64.10%
Aktionäre
Aktionäre
Anteil
Paracchi (Pierluigi)
11.99%
IRCCS Ospedale San Raffaele
9.91%
Naldini (Luigi M.D., Ph.D.)
7.24%
Gentner (Bernard)
3.62%
Russo (Carlo)
3.15%
Andere
64.10%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
26.27%
Corporation
9.91%
Investment Advisor
5.64%
Investment Advisor/Hedge Fund
2.42%
Sovereign Wealth Fund
1.63%
Holding Company
1.22%
Hedge Fund
0.52%
Research Firm
0.01%
Andere
52.38%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
16
1.96M
10.22%
-334.32K
2025Q2
24
9.06M
49.52%
-260.05K
2025Q1
28
9.12M
49.85%
-26.40K
2024Q4
28
8.70M
47.57%
-293.74K
2024Q3
26
8.60M
47.05%
-368.88K
2024Q2
26
8.48M
46.40%
-155.29K
2024Q1
25
8.51M
46.63%
+417.20K
2023Q4
25
8.38M
45.98%
+434.51K
2023Q3
24
8.11M
44.52%
+167.75K
2023Q2
24
8.11M
44.52%
+601.69K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Paracchi (Pierluigi)
2.30M
12.55%
-3.10K
-0.13%
Mar 26, 2025
IRCCS Ospedale San Raffaele
1.90M
10.37%
--
--
Mar 26, 2025
Naldini (Luigi M.D., Ph.D.)
1.39M
7.58%
--
--
Mar 26, 2025
Gentner (Bernard)
692.87K
3.79%
--
--
Mar 26, 2025
Russo (Carlo)
602.42K
3.29%
+4.00K
+0.67%
Mar 26, 2025
Eurizon Capital SGR S.p.A.
360.00K
1.97%
--
--
Aug 31, 2025
Kairos Partners SGR S.p.A.
335.61K
1.83%
-24.00
-0.01%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
311.74K
1.7%
+18.91K
+6.46%
Jun 30, 2025
Investitori SGR S.p.A.
234.05K
1.28%
--
--
Aug 31, 2025
Allianz SE
234.05K
1.28%
+500.00
+0.21%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
